United States · FDA National Drug Code directory
Raloxifene Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16714-213_145e48c3-0ef5-41f7-adc2-ab0a7ca89d87
- Product NDC
- 16714-213
- Form
- TABLET, FILM COATED
- Composition / generic term
- Raloxifene Hydrochloride
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150828
- Source listing expiry
- 20261231
Source-listed ingredients
- RALOXIFENE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (16714-213-01) · 16714-213-01
- 100 TABLET, FILM COATED in 1 BOTTLE (16714-213-02) · 16714-213-02
- 1000 TABLET, FILM COATED in 1 BOTTLE (16714-213-03) · 16714-213-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →